BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18225546)

  • 1. Angiogenesis can be reduced without significant reduction of tumor growth.
    Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
    Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
    Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
    Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
    Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
    Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
    Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
    Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic therapy inhibits human neuroblastoma growth.
    Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
    Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
    Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
    Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease.
    Shusterman S; Grupp SA; Barr R; Carpentieri D; Zhao H; Maris JM
    Clin Cancer Res; 2001 Apr; 7(4):977-84. PubMed ID: 11309349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.
    Kosharskyy B; Solban N; Chang SK; Rizvi I; Chang Y; Hasan T
    Cancer Res; 2006 Nov; 66(22):10953-8. PubMed ID: 17108133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
    Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
    Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
    Bäckman U; Christofferson R
    Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of TNP-470 on hepatic metastasis of mouse neuroblastoma.
    Yoshizawa J; Mizuno R; Yoshida T; Hara A; Ashizuka S; Kanai M; Kuwashima N; Kurobe M; Yamazaki Y
    J Surg Res; 2000 Sep; 93(1):82-7. PubMed ID: 10945947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
    Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
    Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts.
    Segerström L; Fuchs D; Bäckman U; Holmquist K; Christofferson R; Azarbayjani F
    Pediatr Res; 2006 Nov; 60(5):576-81. PubMed ID: 16988184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
    Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
    Rössler J; Monnet Y; Farace F; Opolon P; Daudigeos-Dubus E; Bourredjem A; Vassal G; Geoerger B
    Int J Cancer; 2011 Jun; 128(11):2748-58. PubMed ID: 20715103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin inhibits neuroblastoma tumor growth in mice.
    Svensson A; Azarbayjani F; Bäckman U; Matsumoto T; Christofferson R
    Anticancer Res; 2005; 25(1A):207-12. PubMed ID: 15816540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats.
    Wassberg E; Påhlman S; Westlin JE; Christofferson R
    Pediatr Res; 1997 Mar; 41(3):327-33. PubMed ID: 9078530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
    Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
    Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.